Abcellera Biologics Inc
ABCL.O- Latest Trade
- trading lower10.26USD
- Change
- -0.01
- % Change
0.10%Negative
- Day Range
- 9.97 - 10.44
- 52-Week Range
- 5.42 - 22.63
As of Jun 28 2022. Values delayed up to 15 minutes
- Previous Close
- 10.27
- Open
- 10.22
- Volume
- 613,207.00
- 3 Month Average Trading Volume
- 51.58
- Shares Out (Mil)
- 284.54
- Market Cap
- 3,030.31
- Forward P/E
- 22.01
- Dividend Yield
- -99,999.99
Key Statistics
1.75 mean rating - 8 analysts
- P/E Excl. Extra Items (TTM)
- 16.29
- Price To Sales (TTM)
- 6.20
- Price To Book (Quarterly)
- 2.51
- Price To Cash Flow (Per Share TTM)
- 13.77
- Total Debt/Total Equity (Quarterly)
- 0.00
- Long Term Debt/Equity (Quarterly)
- 0.00
- Return On Investment (TTM)
- 16.93
- Return On Equity (TTM)
- 15.06
2021 (millions USD)
About Abcellera Biologics Inc
Company Information
AbCellera Biologics Inc. (AbCellera) is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera's full-stack, artificial intelligence (AI)-powered drug discovery platform integrates technologies from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning, and hyper-scale data science. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, enabling them to tackle the toughest problems in drug development.
Address
2215 Yukon StreetVANCOUVER, BC
V5Y 0A1
Canada
Industry
Business Services
Executive Leadership
- Carl L. G. Hansen
- Chief Executive Officer, Co-Founder, Director
- Veronique Lecault
- Co-Founder, Chief Operating Officer, Director
- Kevin Heyries
- Co-Founder, Head of Business Development
- Andrew Booth
- Chief Financial Officer
- Ester Falconer
- Chief Technology Officer
- Tryn Stimart
- Chief Compliance Officer, Company Secretary, Chief Legal Officer
- Neil Aubuchon
- Chief Commercial Officer
- Neil Berkley
- Chief Business Officer
- Michael R. Hayden
- Independent Director
- Andrew W. Lo
- Independent Director
- John S. Montalbano
- Independent Director
- Peter Thiel
- Independent Director
Latest News
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,821.60 | 0.04%Positive |
| Copper | 702.30 | 0.75%Positive |
| Brent Crude Oil | 116.96 | 1.62%Positive |
| CBOT Soybeans | 1,655.50 | 1.53%Positive |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 3,874.25 | 0.66%Negative |
| Euro STOXX 50 | 3,547.87 | 0.25%Positive |
| FTSE 100 | 7,323.76 | 0.90%Positive |
| Nikkei 225 | 27,049.47 | 0.66%Positive |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes